Weather Advisory: Temporary Door Closure

Due to extreme cold, access through the Moakley Building's entrance off Boston Medical Center Place will be temporarily closed from 4 p.m. Friday, Feb. 6, through 7 a.m. Monday, Feb. 9.

All patients and visitors should use the main entrance for the Menino and Yawkey Buildings during this time. The hospital remains open and operating as normal.

We appreciate your patience as we take these precautions during severe winter weather.

Language

Perinatal Substance Use Disorders Research

Our research focuses on substance use disorders in pregnancy and substance-exposed newborns. Specifically, we are conducting trials related to pharmacologic treatments for opioid use disorder in pregnancy, cannabis use disorders in pregnancy, placental biomarkers, genetics, pharmacokinetics, fetal alcohol spectrum disorders (FASD), and the long-term childhood outcomes of substance exposure in-utero.

See all of our pediatric research programs.

Contact

Principal Investigator 
Elisha M. Wachman 
Elisha.Wachman@bmc.org 

Project Manager
Chloe Deflorimonte
Chloe.Deflorimonte@bmc.org  

Investigators

Department of Pediatrics 
Elisha M. Wachman, MD
Vincent C. Smith, MD, MPH
Mei Elansary, MD, MPhil
Mark Mirochnick, MD

Department of Obstetrics
Kelley Saia, MD
Erica Holland, MD

substance use disorder in pregnancy team at boston medical center

Research projects

  1. Promoting positive parenting for mothers with OUD: Implementation of a video-coaching intervention in pediatrics (NIH 1K23DA061933)
  2. Boston University Women’s Health Research Affinity Research Collaborative (https://www.bumc.bu.edu/evanscenteribr/2024/08/07/boston-university-wom…)
  3. Boston University BIRCWH Program (NIH 1K12AR085635) (https://www.bu.edu/ctsi/training-education/boston-university-bircwh-pro…)
  4. NICU Withdrawal Assessment Scale (Gerber Foundation) CTN-0080 Medication Treatment for Opioid Use Disorder in Expectant Mothers (MOMS) Randomized Clinical Trial (UG1DA013732), NCT03918850
  5. MAT LINK (Maternal and Infant Network to Understand Outcomes Associated with Medication for Opioid Use Disorder in Pregnancy), https://www.cdc.gov/ncbddd/aboutus/mat-link.html
  6. POD (Placental Markers of Opioid Use Disorder on Development) Study (R01HD113143)
  7. The First Year Study: A Prospective Mixed Methods Study of Maternal and Child Well-being and Risk of Relapse in the First Year Postpartum (BU CTSI)
  8. SAFEST choice: https://www.bmc.org/addiction/training-education/safest-choice
    AAP FASD Toolkit: https://www.aap.org/en/patient-care/fetal-aclohol-spectrum-disorders/
  9. Naltrexone for Cannabis Use Disorder in Pregnancy (BU CTSI)